GlassScriptPhysician profile
Arun Agrawal
NPI 1932300241
$8,806.29
in general payments reported to CMS, 2019-2025
15 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.37 · 2020: $77.87 · 2021: $17.50 · 2022: $121 · 2023: $2,107 · 2024: $6,316 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,514 · Education: $3,016 · Food and Beverage: $2,023 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,514.05 |
| Education | $3,016.24 |
| Food and Beverage | $2,023.05 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,001.19 | 2023-2025 | Da Vinci Surgical System |
| Penumbra, INC. | $1,941.25 | 2023 | Indigo System |
| Astrazeneca Pharmaceuticals LP | $169.33 | 2021-2023 | Fasenra |
| Glaxosmithkline, LLC. | $168.06 | 2023-2025 | Nucala, Trelegy Ellipta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.03 | 2023-2024 | Lifevest |
| Verona Pharma, INC. | $96.65 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $77.87 | 2020 | |
| Janssen Pharmaceuticals, INC | $53.70 | 2019-2024 | Xarelto |
| Genzyme Corporation | $48.70 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.10 | 2023 | Ofev |
| Surmodics, INC. | $36.39 | 2024 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
| United Therapeutics Corporation | $18.45 | 2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $18.12 | 2023 | Keytruda |
| Siemens Medical Solutions USA, INC. | $17.21 | 2024 | Cios Spin |
| Insmed, INC. | $16.24 | 2023 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.